Other top stories

Mediterranean Diet May Reduce Dementia Risk by 23%

March 15, 2023

On Match Day, One Envelope and Countless Emotions Await Med Students

March 15, 2023

Schizophrenia Risk in Diverse Populations Linked to Newly Discovered Genes

March 14, 2023

5 Things to Know About Long COVID and the Brain

March 13, 2023

First Fast-Acting Migraine Nasal Spray Approved by FDA

March 11, 2023

The Weekly Mind Reader: Paradoxical Insomnia, Lithium for Suicide, Mozart for Epilepsy

March 10, 2023

Other stories

3 Case Studies Highlight Rare Neuropsychiatric Symptoms From a COVID Vaccine

March 10, 2023

Mozart's Melodies Fall Flat in Epilepsy Treatment

March 9, 2023

Privacy Concerns Mount Over Telemedicine Company Cerebral

March 8, 2023

11 Antipsychotics and Their Impact on Weight Gain By Dose

March 8, 2023

Why the Fear of Second Hand Fentanyl Smoke May Be Overblown

March 7, 2023

Face Blindness May Affect More than 3% of People, Study Finds

March 6, 2023

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe